Valuation: Mycodern S.A.

Market Cap 51.31M 13.13M 11.72M 10.81M 9.82M 18.43M 1.24B 18.71M 130M 652M 49.28M 48.23M 2.06B P/E 2024
-1.78x
P/E 2025 -215x
Enterprise Value 53.77M 13.76M 12.28M 11.33M 10.29M 19.31M 1.3B 19.61M 137M 683M 51.65M 50.54M 2.16B EV / Sales 2024
26.7x
EV / Sales 2025 -4,565x
Free-Float
10.57%
Yield 2024 *
-
Yield 2025 -
6 months-4.88%
Current year-6.02%
Current year 0.78
Extreme 0.78
0.82
1 year 0.78
Extreme 0.78
0.82
3 years 0.78
Extreme 0.78
2.06
5 years 0.78
Extreme 0.78
4.92
10 years 0.19
Extreme 0.19
4.92
Manager TitleAgeSince
Chief Executive Officer - 2024-08-25
Sales & Marketing - 2021-10-31
Director TitleAgeSince
Director/Board Member - 2022-11-03
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-4.88%-52.44% 13.13M
-0.87%+1.42%+3.67%-14.43% 264B
+3.91%+3.43%+5.20%+1.70% 80.08B
-0.64%+0.68%-20.78%+14.99% 44.96B
+0.60%-3.73%+28.96%+9.60% 38.48B
+4.67%+4.13%-4.65%-8.01% 35.29B
+0.36%-4.09%+19.35%+82.16% 30.64B
+0.03%-2.65%-13.40%-4.62% 28.78B
+6.77%+7.77%-2.15%-19.87% 29.75B
+0.72%-1.07%+2.02%+7.09% 26.34B
Average +1.56%+0.82%+1.33%+1.62% 57.79B
Weighted average by Cap. +0.82%+2.38%+2.76%-1.61%

Financials

2024 2025
Net sales 2.12M 544K 485K 448K 407K 763K 51.51M 775K 5.39M 26.99M 2.04M 2M 85.49M -12.5K -3.2K -2.86K -2.63K -2.39K -4.49K -303K -4.56K -31.73K -159K -12.01K -11.75K -503K
Net income -30.7M -7.86M -7.01M -6.47M -5.88M -11.03M -744M -11.2M -77.94M -390M -29.49M -28.86M -1.24B -254K -65.05K -58.06K -53.56K -48.66K -91.29K -6.16M -92.7K -645K -3.23M -244K -239K -10.23M
Net Debt 2.07M 529K 472K 435K 396K 742K 50.09M 754K 5.25M 26.24M 1.98M 1.94M 83.13M 2.46M 630K 562K 519K 471K 884K 59.68M 898K 6.25M 31.27M 2.37M 2.31M 99.06M
Projected Income Statement - Annual - Mycodern S.A.
Logo Mycodern S.A.
Mycodern SA is a Poland-based company primarily engaged in the food processing. The Company is a producer of functional food and cutting-edge dietary supplements. The company specializes in the production of dietary supplements and functional foods, including the production of vitamin jellies. The company's offer includes products in the form of hard capsules, softgel capsules, functional shots, oil and liquid forms, as well as functional gummies. The Company produces both its own brands and carries out contract orders for other entities. The Company's research and development department allows to develop its own recipes. The Company's products are sold in over 25 countries, including Europe and beyond. The Company has a modern machine park and develops distribution channels.
Employees
23